Millipore Sigma Vibrant Logo

208712 Calpain-1, Porcine Erythrocytes

Calpain-1, Porcine Erythrocytes, is a native calpain-1. A heterodimeric cysteine proteinase with low Ca2+ requirement (EC₅₀ = 2 µM).

Calpain-1, Porcine Erythrocytes: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: μ-Calpain

View Products on Sigmaaldrich.com
208712
Preis & Verfügbarkeit

Übersicht

Replacement Information

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
208712-1MG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 1 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewNative calpain-1 from porcine erythrocytes. Ca2+-dependent heterodimeric cysteine proteinase with low Ca2+ requirement (EC50= 2 µM). Participates in the ATP release reaction of platelets stimulated with thrombin.
      Catalogue Number208712
      Brand Family Calbiochem®
      Synonymsμ-Calpain
      References
      ReferencesVanderklish, P.W., and Bahr, B.A. 2000. Int. J. Exp. Pathol. 81, 323.
      Sorimachi, H., et al. 1997. Biochem. J. 328, 721.
      Kampfl, A., et al. 1997. J. Neurotrauma 14, 121.
      Johnson, G.V.W., and Gutmann, R.P. 1997. BioEssays 19, 1011.
      Bartus, R.T., et al. 1995. Neurol. Res. 17, 249.
      Wang, K.K.W., and Yuen, P.-W. 1994. Trends Pharmacol. Sci. 15, 412.
      Saito, K., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 2628.
      Goll, D.E., et al. 1992. BioEssays 14, 549.
      Ishii, H., et al. 1992. Biochim. Biophys. Acta 1175, 37.
      Melloni, E., and Pontremoli, S. 1989. Trends Neurosci. 12, 438.
      Ross, E., and Schatz, G. 1973. Anal. Biochem. 54, 304.
      Product Information
      Unit of DefinitionOne unit is defined as the amount of enzyme that will hydrolyze 1 pmol Suc-LLVY-AMC in 1 min at 25°C using the Calpain Activity Assay Kit, Fluorogenic (Cat. No. QIA120). Note: 1 caseinolytic unit = 9 fluorogenic units
      EC number3.4.22.17
      FormLiquid
      FormulationIn 20 mM imidazole-HCl, 5 mM β-mercaptoethanol, 1 mM EDTA, 1 mM EGTA, 30% glycerol, pH 6.8.
      PI5.3
      Quality LevelMQ100
      Applications
      Biological Information
      Specific Activity≥1000 units/mg protein
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/37/38-42/43

      Irritating to eyes, respiratory system and skin.
      May cause sensitization by inhalation and skin contact.
      S PhraseS: 26-36

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Harmful
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C). Short-term storage of aliquots at 4°C or on ice is not recommended.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      208712-1MG 04055977202632

      Documentation

      Calpain-1, Porcine Erythrocytes SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Calpain-1, Porcine Erythrocytes Analysenzertifikate

      TitelChargennummer
      208712

      Literatur

      Übersicht
      Vanderklish, P.W., and Bahr, B.A. 2000. Int. J. Exp. Pathol. 81, 323.
      Sorimachi, H., et al. 1997. Biochem. J. 328, 721.
      Kampfl, A., et al. 1997. J. Neurotrauma 14, 121.
      Johnson, G.V.W., and Gutmann, R.P. 1997. BioEssays 19, 1011.
      Bartus, R.T., et al. 1995. Neurol. Res. 17, 249.
      Wang, K.K.W., and Yuen, P.-W. 1994. Trends Pharmacol. Sci. 15, 412.
      Saito, K., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 2628.
      Goll, D.E., et al. 1992. BioEssays 14, 549.
      Ishii, H., et al. 1992. Biochim. Biophys. Acta 1175, 37.
      Melloni, E., and Pontremoli, S. 1989. Trends Neurosci. 12, 438.
      Ross, E., and Schatz, G. 1973. Anal. Biochem. 54, 304.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-May-2010 JSW
      Synonymsμ-Calpain
      DescriptionNative calpain-1 from porcine erythrocytes. Calpains are a family of calcium-dependent thiol-proteases that degrade a wide variety of cytoskeletal, membrane-associated, and regulatory proteins. The two major isoforms, calpain I (µ-form) and calpain II (m-form), differ in their calcium requirement for activation. Calpain I requires only micromolar amounts of calcium (EC50 = 2 µM), while calpain II requires millimolar amounts (EC50 = 1 mM).

      Calpains are heterodimers of 80 kDa and 30 kDa subunits. The 80 kDa unit has the catalytic site and is unique to each isozyme. The 30 kDa unit is a regulatory subunit and common to both calpain I and calpain II. The 80 kDa unit consists of four domains (I-IV). The 30 kDa unit has two domains (V and VI).

      • Domain I is partially removed during autolysis.
      • Domain II is the protease domain.
      • Domain III exhibits a homology with typical calmodulin binding proteins and interacts with calcium binding domains (IV and VI) and frees domain II for protease activity.
      • Domain IV is a calcium binding domain.
      • Domain V contains a hydrophobic region and is essential for calpain interaction with membranes.
      • Domain VI is a calcium binding domain.

      More recently, attention has been focused on the pathological significance of calcium accumulation in the central nervous system following cerebral ischemia and traumatic brain injury. Over-activation of NMDA, kainate, and AMPA receptors in the brain leads to sustained influx in Ca2+ through voltage gated Ca2+ channels. Disturbances in calcium homeostasis result in the activation of several calcium-dependent enzymes including calpains. Over-expression of calpains has been positively linked to both acute and chronic neurodegenerative processes including ischemia, trauma, and Alzheimer's disease. In Alzheimer's disease the ratio of active (76 kDa) to inactive (80 kDa) calpain I is reported to be much higher. Calpain proteolysis is usually the late-stage common pathway towards cell death induced by excitotoxic compounds.
      FormLiquid
      FormulationIn 20 mM imidazole-HCl, 5 mM β-mercaptoethanol, 1 mM EDTA, 1 mM EGTA, 30% glycerol, pH 6.8.
      Concentration Label Please refer to vial label for lot-specific concentration
      EC number3.4.22.17
      Specific activity≥1000 units/mg protein
      Unit definitionOne unit is defined as the amount of enzyme that will hydrolyze 1 pmol Suc-LLVY-AMC in 1 min at 25°C using the Calpain Activity Assay Kit, Fluorogenic (Cat. No. QIA120). Note: 1 caseinolytic unit = 9 fluorogenic units
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C). Short-term storage of aliquots at 4°C or on ice is not recommended.
      Toxicity Harmful
      ReferencesVanderklish, P.W., and Bahr, B.A. 2000. Int. J. Exp. Pathol. 81, 323.
      Sorimachi, H., et al. 1997. Biochem. J. 328, 721.
      Kampfl, A., et al. 1997. J. Neurotrauma 14, 121.
      Johnson, G.V.W., and Gutmann, R.P. 1997. BioEssays 19, 1011.
      Bartus, R.T., et al. 1995. Neurol. Res. 17, 249.
      Wang, K.K.W., and Yuen, P.-W. 1994. Trends Pharmacol. Sci. 15, 412.
      Saito, K., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 2628.
      Goll, D.E., et al. 1992. BioEssays 14, 549.
      Ishii, H., et al. 1992. Biochim. Biophys. Acta 1175, 37.
      Melloni, E., and Pontremoli, S. 1989. Trends Neurosci. 12, 438.
      Ross, E., and Schatz, G. 1973. Anal. Biochem. 54, 304.

      Verwandte Produkte & Anwendungen

      Related Products

      Bestellnummer Beschreibung  
      208713 Calpain-1, Human Erythrocytes Preis & Verfügbarkeit
      208715 Calpain-2, Porcine Kidney Preis & Verfügbarkeit
      208718 Calpain-2, Rat, Recombinant, High Purity, E. coli Preis & Verfügbarkeit

      Kategorien

      Life Science Research > Proteins and Enzymes > Other Enzymes